title: Severe adverse cardiovascular effects of pulse steroid therapy: is continuous cardiac monitoring necessary?
abstract: Pulse steroid therapy (PST) has been used in dermatology to treat a variety of severe inflammatory disorders. Dermatologists have usually recommended that patients be hospitalized for continuous cardiac monitoring during PST administration, although specialists in other fields have administered PST in an outpatient setting. We reviewed the literature concerning serious adverse cardiovascular effects of PST. These were rare and have been mainly reported in nondermatologic patients, typically those with kidney or heart disease. Although outpatient administration of PST may be a safe practice for some dermatologic patients, we cannot make a firm recommendation without a prospective trial.
authors.affiliation: Department of Medicine, University of Connecticut Health Center.
authors.forename: K P
authors.initials: KP
authors.lastname: White
authors.forename: M S
authors.initials: MS
authors.lastname: Driscoll
authors.forename: M J
authors.initials: MJ
authors.lastname: Rothe
authors.forename: J M
authors.initials: JM
authors.lastname: Grant-Kels
mesh_terms: D015716:Electrocardiography, Ambulatory; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000009:adverse effects*; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000150:complications; D012871:Skin Diseases / Q000150:complications / Q000188:drug therapy*
chemical_list: D005938:Glucocorticoids